Capping Off a Year of Aggressive Action on Abortion, White House Announces ‘Fight for Reproductive Freedoms Tour’

Michie

Well-Known Member
Site Supporter
Feb 5, 2002
166,617
56,253
Woods
✟4,675,149.00
Country
United States
Faith
Catholic
Marital Status
Married
Politics
US-Others
After a year of promoting abortion access despite recent Supreme Court rulings, the Biden Administration is doubling down as we enter into 2024.

The White House announced Tuesday that Vice President Kamala Harris will go on a “Fight for Reproductive Freedoms” tour across the country in 2024. The tour will begin in Wisconsin on Jan. 22 — the 51st anniversary of the Roe v. Wadedecision which widely legalized abortion in 1973 before it was overturned in the Supreme Court’s June 2022 Dobbs v. Jackson Women’s Healthdecision returning the issue to the states.

The announcement indicates that the Biden administration will continue to focus on expanding access to abortion following a year of executive action and guidance on the issue, as 14 states have put pro-life laws in place barring abortion in most cases.

Expanding Abortion Pill Access

At the very beginning of 2023, the Food and Drug Administration said it would allow any patient with a prescription to obtain the abortion inducing drug mifepristone from a local retail pharmacy that is certified to dispense the drug. Previously, the drug could only be obtained through certified doctors, abortion facilities, and some mail-order pharmacies.

The Biden administration identified access to the abortion drug mifepristone as a “key priority” following the Dobbs ruling. This year, it has been defending the push for wider abortion pill access in the Alliance for Hippocratic Medicine v. FDA case. Pro-life groups and individuals filed suit in November 2022 alleging that the U.S. Food and Drug Administration disregarded safety concerns and protocols in approving and deregulating the abortion pill.

Continued below.